Upcoming Financial Results for Venus Concept
Venus Concept Inc. announces that it will release its financial results for the third quarter of the fiscal year 2024 before the market opens on Wednesday, November 13, 2024. This release will provide valuable insight into the Company's performance within the medical aesthetic technology sector.
Conference Call Details
The management team at Venus Concept will host a conference call to discuss these results, scheduled for 8:00 a.m. Eastern Time on the same day. This will be an opportunity for shareholders and stakeholders to engage directly with management during a question and answer session. Interested parties can join the call by dialing the toll-free number 877-407-2991, or for those calling internationally, 201-389-0925. Participants will need to provide the access code 13749236 to join the discussion.
Webcast Availability
For those unable to participate in real-time, a replay of the conference call will be available for two weeks at 877-660-6853 (with international callers using 201-612-7415). The access code remains the same for the replay. Additionally, a recording of the webcast will be archived on the Company's investor relations section at ir.venusconcept.com.
Overview of Venus Concept
Venus Concept is recognized as a leader in the global medical aesthetic technology field, offering a wide range of minimally invasive and non-invasive solutions. The Company effectively delivers its innovative products across more than 60 countries, enhancing the lives and aesthetics of individuals worldwide.
Product Portfolio Highlights
The robust product portfolio of Venus Concept includes advanced aesthetic device platforms such as Venus Versa, Venus Legacy, and Venus Bliss, among others. Additionally, their hair restoration systems, including NeoGraft and the ARTAS iX Robotic Hair Restoration system, mark significant achievements in the field. This extensive catalog underlines the Company's commitment to innovation and quality in medical aesthetics.
Support from Equity Investors
Venus Concept has garnered backing from prominent growth equity investors, including EW Healthcare Partners, HealthQuest Capital, and Longitude Capital Management, which emphasizes the trust and confidence in its operational and market strategies. This support has been instrumental in driving further growth and expansion in the medical aesthetic industry.
Investor Relations Contact
For additional information related to investor relations or inquiries, please contact:
Mike Piccinino, CFA
ICR Westwicke on behalf of Venus Concept
Email: VenusConceptIR@westwicke.com
Frequently Asked Questions
When will Venus Concept release its Q3 financial results?
Venus Concept plans to release its third quarter financial results on November 13, 2024, before the market opens.
What time is the conference call scheduled for?
The conference call will take place at 8:00 a.m. Eastern Time on November 13, 2024.
How can I participate in the conference call?
Participants can join the call by dialing 877-407-2991 and providing the access code 13749236, or by calling internationally at 201-389-0925.
Is there a way to access a replay of the conference call?
Yes, a replay will be available for two weeks by calling 877-660-6853, and the access code is the same as for the live call.
What information can I find on the Company’s website?
The investor relations section of the Company's website will host the archived webcast of the conference call, along with other important investor information.
